Navigation Links
The new born nightmare

Newborns are more likelier to develop a serious intestinal disorder if they are given the commonly prescribed antibiotic erythromycin, say US scientists. A research team from Lousiana University has linked use of this drug to pyloric stenosis, a condition that affects about 1 in 400 newborns and it is the most common cause of abdominal surgery in infants.

Using the Regenstrief Medical Record System – a comprehensive database that stores information on diagnoses, operative reports, pharmacy records and physician observations –the investigators studied 13,576 babies born between January 1995 and December 2000.//

They found that those babies given oral erythromycin during the first two weeks of life were 12 times more likely to develop pyloric stenosis than those who were not, although babies treated with erythromycin eye ointment, which is regularly used to combat conjunctivitis, did not have much risk.

“The link between erythromycin and pyloric stenosis is an important finding which will make a difference to the health of babies,” said Dr Lida Carlman, the lead researcher, adding that the study was only made possible by the vast amount of data stored in the Regenstrief system.

The researchers conclude that erythromycin should be used with great precaution in a baby’s first four weeks of life.
br>
'"/>




Page: 1

Related medicine news :

1. Wake-up Call: Two-thirds of Briton Spend Many Sleeping Moments Awake!
2. A Wake-up Call by MPs to Ensure Timely Care to Stroke Victims
3. Stem cell cure for peripheral vascular disease: New hope on the horizon
4. New device for detecting artery blockages
5. Vitamins suppress artery injury after transplant
6. Cocaine may cause aneurysms for the coronart artery
7. Soy, Omega 3s convalesce artery health
8. Erectile dysfunction: an early warning sign of clinically silent coronary artery disease?
9. Experts urging artery screening in the UK
10. Evidence Links Protein Damage to Neurodegenerative diseases like Parkinsons and Alzheimers
11. Fight Heart disease and Pain with Meditation
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s National ... 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. ... for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned and ... 2017 Best and Brightest in Wellness® by Best and Brightest. OnSite Wellness will ... Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at the Henry Autograph ...
(Date:10/12/2017)... ... October 12, 2017 , ... In the United States, single-family ... some states—like New York, New Jersey, Massachusetts, Texas, Virginia, Connecticut, and California—the average ... extremely low property-tax rates, which contributes to the relatively lower cost of living ...
(Date:10/12/2017)... ... October 12, 2017 , ... Farm ... California Berkeley, and other leading institutions in announcing the launch of the ... change the way animals are raised for food. , Founding members of the ...
(Date:10/12/2017)... ... October 12, 2017 , ... Nvision Biomedical ... staff with the addition of industry sales leader, Thomas (Tom) Slott, as Senior ... national distribution and sales network, direct the efforts of the surgical sales teams, ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... YORK , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a ... today announced that its MyDario product is expected to appear on The ... when The Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz ... The ...
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
(Date:9/19/2017)... HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that ... developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and ...
Breaking Medicine Technology: